The company, which developed an app that helps people lose weight by focusing on behavioral change, launched a new service to offer a compounded GLP-1 drug at a starting price of $149 for the first month and then $279 for subsequent months
Heres what should be on that shopping list: Here's the scoop from Healthline and Medical News Today
Another 2024 study found that people with breast cancer and type 2 diabetes taking GLP-1 drugs had fewer major cardiovascular problems (conditions related to heart and blood vessels) after receiving cardiotoxic breast cancer treatments such as anthracyclines and HER2 inhibitors, compared to people not taking GLP-1 drugs
When it comes to unapproved peptides like BPC-157, he has made an additional argument: These substances are already on the gray market, raising the risk that someone may be harmed by a mislabeled or contaminated product
The FDA approved Rybelsus, an oral version of semaglutide manufactured by the drug company Novo Nordisk, in 2019